This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider about your specific health needs and treatment options.
By TutelaMedical.com Health Research Team | Updated July 2026
Quick Comparison: Semaglutide vs. Tirzepatide
- Semaglutide (Ozempic/Wegovy): Works on one hormone pathway. FDA-approved for weight loss. Average weight loss about 15% of body weight.
- Tirzepatide (Mounjaro/Zepbound): Works on TWO hormone pathways. FDA-approved for weight loss. Average weight loss about 21% of body weight in clinical trials.
- Side effects: Both can cause nausea, constipation, and diarrhea. Very similar profiles overall.
- Cost: Semaglutide roughly $1,000-$1,200/month; tirzepatide roughly $1,200-$1,600/month without insurance.
- Most prescribed first: Semaglutide — it has been around longer and has more insurance coverage history.
- Important: You typically need to stay on these medications long-term. Weight often returns if you stop.
What Are GLP-1 Medications? The Basics
GLP-1 medications are a new type of drug that help people lose weight and manage their appetite. The name comes from a hormone your body naturally makes called glucagon-like peptide-1 (a chemical messenger that tells your body important information).
Here's how it works: When you eat, your gut releases GLP-1 naturally. This hormone travels to your brain and essentially says, “Hey, you're full. Stop eating now.” It also slows down how fast your stomach empties, so food stays in your belly longer and keeps you feeling satisfied.
The problem: People who struggle with weight don't have enough of this hormone, or their bodies don't respond to it well. So they stay hungry even after eating a lot.
The solution: These medications inject extra GLP-1 (or mimic it) into your body. More of this “you're full” signal means less hunger, smaller portions, and — for many people — significant weight loss.
Semaglutide: The First-to-Market Option
How It Works
Semaglutide targets ONE hormone pathway: GLP-1 only. It's like having a single switch that turns up your fullness signal.
The medication was first approved by the FDA (Food and Drug Administration) in 2021 for weight loss under the brand name Wegovy. It was already on the market as Ozempic for diabetes management, but at lower doses.
Weight Loss Results
In major clinical trials (called the STEP trials), people taking semaglutide lost an average of about 15% of their body weight. This means if you weigh 200 pounds, you might lose about 30 pounds.
Results varied by individual. Some people lost more, some less. The dose mattered too — higher doses produced more weight loss.
How You Take It
Semaglutide is a weekly injection. You give yourself a shot under the skin (usually in your thigh, belly, or upper arm) once per week. Most people find this easy to do at home.
Tirzepatide: The Newer, “Dual Action” Option
How It Works
Tirzepatide is newer and works differently. Instead of targeting just one hormone pathway, it targets TWO: both GLP-1 AND GIP.
Think of it like this: Semaglutide is a single-lane highway telling your brain you're full. Tirzepatide is a two-lane highway sending that message twice as loud.
GIP is another gut hormone that also affects hunger and how your body uses energy. By hitting both pathways, tirzepatide creates a stronger “I'm satisfied” signal.
Tirzepatide was approved by the FDA in 2023 under the brand names Mounjaro (for diabetes) and Zepbound (for weight loss).
Weight Loss Results
In the major clinical trials (called the SURMOUNT trials), people taking tirzepatide lost an average of about 21% of their body weight. Using our earlier example, that same 200-pound person might lose about 42 pounds.
That's significantly more than semaglutide in head-to-head comparisons. However, individual results still vary — some people respond better to one medication than the other.
How You Take It
Like semaglutide, tirzepatide is a weekly injection you give yourself at home. The injection process is identical.
Head-to-Head: The Clinical Trial Comparison
STEP Trials (Semaglutide)
- Average weight loss: ~15% of body weight
- Study duration: 68 weeks
- Participants: Several thousand people
- Finding: Effective for weight loss and improved metabolic health
SURMOUNT Trials (Tirzepatide)
- Average weight loss: ~21% of body weight
- Study duration: 72 weeks
- Participants: Several thousand people
- Finding: Greater weight loss than semaglutide, with similar safety profile
The bottom line: In clinical trials, tirzepatide produced more weight loss on average. But “on average” is key — individual responses vary widely. Some people lose more on semaglutide, and some plateau on tirzepatide.
Side Effects: How Do They Compare?
The Similarities
Both medications cause very similar side effects because they work on the same gut-hormone system:
- Nausea (especially at the start or when doses increase)
- Constipation (very common)
- Diarrhea (also common)
- Vomiting (less common, but can happen)
- Loss of appetite (this is actually the goal, but some people find it extreme)
- Fatigue or feeling tired
The Differences
Tirzepatide may cause slightly more nausea because it's more powerful — it creates a stronger signal in your gut. However, this is not universal. Some people tolerate tirzepatide better than semaglutide.
Both medications improve significantly after a few weeks. Your body adapts to nausea. Most people report their side effects almost disappear by month two or three.
Serious But Rare Side Effects
There are concerns about a rare condition called pancreatitis (inflammation of the pancreas, an organ that helps digest food). This is very uncommon, but it's on the warning label for both drugs.
There's also ongoing research about potential thyroid concerns with these medications. If you have a personal or family history of thyroid cancer, talk to your doctor before starting either medication.
Cost and Insurance Coverage
Out-of-Pocket Prices (Without Insurance)
Semaglutide (Wegovy): About $1,000-$1,200 per month
Tirzepatide (Zepbound): About $1,200-$1,600 per month
Tirzepatide is typically more expensive because it's newer.
With Insurance
Insurance coverage varies dramatically. Some plans cover semaglutide fully; others cover neither drug. Some require you to try semaglutide first before approving tirzepatide.
Why the difference? Semaglutide has been around longer for weight loss, so insurance companies have more data about it. It's also cheaper, which insurers prefer.
If cost is a barrier, ask your doctor about patient assistance programs (company-run programs that help people afford medications). Both Novo Nordisk (semaglutide maker) and Eli Lilly (tirzepatide maker) offer these.
Which Do Doctors Prescribe First?
Most doctors start with semaglutide for several reasons:
- History: It's been used for weight loss longer, so doctors know it well.
- Insurance: Insurance companies are more likely to cover it.
- Cost: It's slightly cheaper.
- Safety track record: More people have used it, so fewer unknowns.
However, if semaglutide doesn't work well for you (you're not losing weight, or side effects are intolerable), doctors will often switch you to tirzepatide. Some people simply respond better to the dual-hormone approach.
How Long Do You Need to Stay On These Medications?
This is the reality many people don't want to hear: These are long-term medications, probably for life.
Here's what the research shows:
- When you stop taking semaglutide or tirzepatide, the weight typically comes back.
- Studies show people regain about two-thirds of the weight they lost within a year of stopping.
- Your appetite returns to its previous level because the medication's effect stops.
Think of it like this: These medications treat appetite the same way blood pressure medication treats high blood pressure. You wouldn't expect to take blood pressure medicine for a year and then stop forever. Same concept here.
Some people can eventually stop if they've made permanent lifestyle changes (diet and exercise habits that stick). But most people need to stay on the medication to maintain their weight loss.
What Happens When You Stop?
The Timeline
Week 1-2: Appetite starts returning. The medication leaves your system fairly quickly.
Month 1-3: Hunger comes back stronger. You may start eating larger portions again without realizing it.
Month 3-12: Gradual weight gain begins. Most of the weight lost comes back.
Can You Prevent This?
Some people successfully maintain weight loss after stopping if they've built lasting habits. But research shows this is the exception, not the rule.
Many people find it easier to stay on a low dose of the medication long-term rather than struggle with weight regain.
Side-by-Side Comparison Table
| Feature | Semaglutide (Wegovy) | Tirzepatide (Zepbound) |
|---|---|---|
| How many hormones targeted | 1 (GLP-1 only) | 2 (GLP-1 + GIP) |
| FDA approval for weight loss | 2021 | 2023 |
| Average weight loss | ~15% of body weight | ~21% of body weight |
| How to take it | Weekly injection | Weekly injection |
| Most common side effects | Nausea, constipation, diarrhea | Nausea (slightly more common), constipation, diarrhea |
| Monthly cost (no insurance) | $1,000-$1,200 | $1,200-$1,600 |
| Insurance coverage | More common | Less common (so far) |
| Usually prescribed first | Yes | Usually second |
| Weight regain after stopping | Most weight returns | Most weight returns |
Which One Is Right for You?
Semaglutide might be better if:
- You want to start with a well-established medication
- Cost is a major factor
- Insurance is more likely to cover it
- You're sensitive to side effects and want the gentler option
Tirzepatide might be better if:
- You want maximum weight loss potential
- Semaglutide didn't work well for you
- You can afford the higher cost
- Your insurance covers it or you have patient assistance available
The honest truth: The “best” medication is the one that works for YOUR body and your situation. Some people lose dramatically more on one versus the other. The only way to know is to try one under your doctor's supervision.
Key Takeaways
- Both work. Semaglutide and tirzepatide both help people lose significant weight by mimicking a natural fullness hormone.
- Tirzepatide is stronger on average. Clinical trials show about 6% more weight loss, but individual results vary greatly.
- Side effects are similar and usually temporary. Nausea fades for most people within weeks.
- Cost matters. Semaglutide is slightly cheaper and more likely to be covered by insurance currently.
- Semaglutide is prescribed first usually. But if it doesn't work, tirzepatide is a logical next step.
- These are long-term commitments. Most people regain weight if they stop. Plan on staying on the medication to keep the weight off.
- Work with your doctor. They'll consider your health history, budget, insurance, and goals to recommend the best option for you.
Medical Disclaimer: This article provides general educational information about semaglutide and tirzepatide. It is not a substitute for professional medical advice, diagnosis, or treatment. Individual responses to medication vary. Serious side effects, though rare, can occur. Always discuss treatment options with a qualified healthcare provider who understands your complete medical history, current medications, and specific health conditions before starting any new medication. If you experience severe side effects, contact your healthcare provider or emergency services immediately.
Recent Research Context
Both semaglutide and tirzepatide are subjects of ongoing research beyond their approved uses. In July 2026, headlines about an “Ozempic pill” for alcohol cravings drew widespread attention. Our headline fact-check clarifies what the actual studies tested and found.